JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma

Podcast: Journal of Clinical Oncology (JCO) Podcast · American Society of Clinical Oncology (ASCO)

Opublikowano: 2026-06-01

JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper "Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study." LINK TO FULL TRANSCRIPT